ArticleCell reports. Medicine2026

Valrubicin-loaded immunoliposomes targeting antigens on immunosuppressive cells to circumvent resistance to cancer immunotherapy.

Aleksandra Georgievski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.